Not really, GSK3b is downstream of the bind between Wnt and Frizzled. Not upstream as I said.That's what GSK3b is
In conversation with Samumed CEO Osman Kibar: Drugging Wnt, restoring youth and unconventional capital
Founded in 2008, Samumed has spent most of its lifetime working under the radar. | Samumed CEO Osman Kibar discusses regenerative medicine, drugging the Wnt pathway and his company's unorthodox journey.
www.fiercebiotech.com
"What’s more, hitting Wnt receptors hard can backfire. A drug may have its intended effect, but it may disrupt other processes, leading to side effects and safety concerns. So, instead of aiming at Wnt receptors on the cell membrane, Samumed’s drugs target CLK and DYRK, kinase enzymes that are upstream of the Wnt pathway. "
I was talking about the modulation of CLK and DYRK.